1. Home
  2. WHWK vs NVX Comparison

WHWK vs NVX Comparison

Compare WHWK & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.39

Market Cap

179.8M

Sector

Health Care

ML Signal

HOLD

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

HOLD

Current Price

$0.75

Market Cap

144.3M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHWK
NVX
Founded
2007
2012
Country
United States
Australia
Employees
22
192
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
179.8M
144.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WHWK
NVX
Price
$3.39
$0.75
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
180.7K
366.9K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3,904.19
Revenue Next Year
N/A
$91.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.61
52 Week High
$4.40
$3.86

Technical Indicators

Market Signals
Indicator
WHWK
NVX
Relative Strength Index (RSI) 46.33 48.96
Support Level $1.84 $0.62
Resistance Level $3.79 $0.81
Average True Range (ATR) 0.24 0.05
MACD -0.03 0.01
Stochastic Oscillator 33.58 67.85

Price Performance

Historical Comparison
WHWK
NVX

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

Share on Social Networks: